Nonclinical services for the development of interventional agents for infectious diseases.
Ended Awarded Last action
- Contract number
- 75N93021F00001
- Awardee
-
Research Triangle Institute UEI JJHCMK4NT5N3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $514,189
Award facts
- Contract value 100% obligated
- $514,188.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Award Fee
- Place of performance
- Durham, NC 27709, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$30,653 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Original award | $544,842 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Research Triangle Institute (doing business as RTI International) on January 1, 2021, under the Nonclinical Services for Development of Interventional Agents parent IDIQ for nonclinical services supporting the development of interventional agents for infectious diseases. The order carries a ceiling value of $514,188.92 and is priced on a cost-plus-award-fee basis.
Place of performance is Durham, North Carolina. The order's ultimate completion date is April 30, 2022.
Service Contract Inventory reporting shows the order invoiced $1 thousand in FY2021 (3 contractor hours at $305.34 per hour) and $513 thousand in FY2022 (18 contractor hours at $28,510.24 per hour). RTI self-performed all reported hours with no subcontractors. The order was issued to support de-obligation of expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability for those funds.
Quick answers
Who was awarded contract 75N93021F00001?
75N93021F00001 was awarded to Research Triangle Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 1, 2021.
How much is contract 75N93021F00001 worth?
The government has obligated $514,189 on 75N93021F00001.
Is contract 75N93021F00001 an order under another contract?
Yes. 75N93021F00001 is a delivery order under 75N93018D00002, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93021F00001 competed?
The extent of competition for 75N93021F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award